The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial
bioRxiv (2022) - Comments
doi: 10.1101/2022.03.22.22272739 

Thuy P. Nguyen, Quyet Do, Lan T. Phan, Dang D. Anh, Hiep Khong, Thuong V. Nguyen, Luong V. Hoang, Duc V. Dinh, Hung N. Pham, Men V. Chu, Toan T. Nguyen, Quang D. Pham, Tri M. Le, Tuyen N.T. Trang, Thanh T. Dinh, Thuong V. Vo, Thao T. Vu, Quynh B.P. Nguyen, Vuong T. Phan, Luong V. Nguyen